Categories AlphaGraphs, Earnings, LATEST, Technology

Fitbit recovers top line in Q3 as fight with Apple Watch intensifies

Wearables veteran Fitbit (FIT) on Wednesday posted slight improvement in revenue of $394 million from last year’s $392.5 million, just beating Street estimates. Shares reacted to the news positively, sending the stock more than 10% up as high as $5.29 in aftermarket trade from its closing price of $4.73.

However, it saw a loss of $0.01 per share. Adjusted earnings was $0.04 a share on a net loss of only $0.21 million, much lower than last year’s loss of $113.4 million.

Analysts expected a revenue of $381.2 million, 3% short of a year ago generating an adjusted loss of $0.01 a share. Avoiding a double-digit percentage drop on the top line in itself was touted to be a silver lining for the company, but now it has improved it.

 

Fitbit Q3 earnings - wearable companies shipments market share

 

Three months ago, Fitbit saw a loss and declining sales for the seven straight quarters in a row. Revenue of Fitbit slipped 15.3% to below $300 million, posting a net loss of $118.3 million or $0.49 per diluted share. Cutting the cycle might now present a good opportunity for Fitbit to get back into the game, especially when the company that is looking to track your health is having trouble keeping itself above the water.

It is true that the once leading maker of fitness bracelets has fallen on hard times lately, especially with the advent of the Apple (AAPL) Watch. Shares have been falling sharply for the third consecutive year, shedding off 92% of their value since hitting its peak after its 2015 IPO.

 

Fitbit (FIT) Q3 2018 Earnings Results

 

 

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top